Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Buchanan, James ^a   Mihaylova, Borislava ^a   Gray, Alastair ^a   White, Nicholas ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT;

AFRICA; ARTICLE; ASIA; BACTERIAL INFECTION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEVER; HEALTH CARE COST; INCIDENCE; MALARIA; MORTALITY; PATIENT REFERRAL; CHILD; COST BENEFIT ANALYSIS; HEALTH CARE DELIVERY; HUMAN; METABOLISM; MICROBIOLOGY; PRESCHOOL CHILD; RECTAL DRUG ADMINISTRATION;

BACTERIA (MICROORGANISMS);

ADMINISTRATION, RECTAL; AFRICA; ANTI-INFECTIVE AGENTS; ANTIMALARIALS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; FEVER; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA;

EID: 78650821953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014446     Document Type: Article

References (58)

1. World Health Organisation (2008) The global burden of disease: 2004 update.
2. Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, et al. (2009) Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. The Lancet 373: 557-566.
3. Kallander K, Nsungwa-Sabiiti J, Peterson S (2004) Symptom overlap for malaria and pneumonia-policy implications for home management strategies. Acta Trop 90: 211-214.
4. Noedl H (2009) ABC-antibiotics-based combinations for the treatment of severe malaria? Trends in Parasitology 25: 540-544.
5. Sigauque B, Roca A, Bassat Q, Morais L, Quinto L, et al. (2009) Severe Pneumonia in Mozambican Young Children: Clinical and Radiological Characteristics and Risk Factors. J Trop Pediatr 55: 379-387.
6. World Health Organisation and UNICEF (2004) Management of pneumonia in community settings.
7. World Health Organisation (2010) Guidelines for the treatment of malaria. Geneva.
8. World Health Organisation and UNICEF (2008) Integrated management of childhood illlness.
9. World Health Organisation (2009) Acute respiratory infections in children.
10. World Health Organisation (2008) World Malaria Report.
11. UNICEF (2008) The State of the World's Children 2008.
12. Department of Economic and Social Affairs (2006) Demographic Yearbook. United Nations.
13. World Health Organisation (2000) Management of severe malaria: A practical handbook.
14. Goodman C, Coleman P, Mills A (2000) Economic Analysis of Malaria Control in Sub-Saharan Africa. World Health Organisation.
15. Goodman C, Coleman P, Mills A (2001) Changing the first line drug for malaria treatment-cost-effectiveness analysis with highly uncertain inter-temporal tradeoffs. Health Economics 10: 731-749.
16. Goodman CA, Coleman PG, Mills AJ (1999) Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 354: 378-385.
17. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, et al. (2008) Costeffectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bulletin of the World Health Organization 86: 81-160.
18. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H (2004) Global estimate of the incidence of clinical pneumonia among children under five years of age. Bulletin of the World Health Organization 82: 895-903.
19. Rudan I (2008) Epidemiology and etiology of childhood pneumonia. Bulletin of the World Health Organization 86: 408.
20. World Health Organisation (2000) Management of the child with a serious infection or severe malnutrition: Guidelines for care at the first-referral level in developing countries.
21. UNICEF (2006) Pneumonia: the forgotten killer of children.
22. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, et al. (2008) The Limits and Intensity of Plasmodium falciparum Transmission: Implications for Malaria Control and Elimination Worldwide. PLoS Medicine 5: e38. doi:10.1371/journal.pmed.0050038.
23. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, et al. (2008) The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ 336: 202-205.
24. Lim Y-W, Steinhoff M, Girosi F, Holtzman D, Campbell H, et al. (2006) Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics. Nature 444: 9-18.
25. Lim Y-W, Girosi F, Boer R (2006) A Technical Supplement: Reducing the Global Burden of Acute Lower Respiratory Infections in Children. RAND Health working paper.
26. Dondorp A, Fanello CI, Hendriksen ICE, Gomes E, Seni A, et al. (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. The Lancet 376: 1647-1657.
27. Dondorp A, Nosten F, Stepniewska K, Day N, White N (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. The Lancet 366: 717-725.
28. Dondorp Arjen M, Lee Sue J, Faiz MA, Mishra S, Price R, et al. (2008) The Relationship between Age and the Manifestations of and Mortality Associated with Severe Malaria. Clinical Infectious Diseases 47: 151-157.
29. Duke T, Poka H, Dale F, Michael A, Mgone J, et al. (2002) Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. The Lancet 359: 474-480.
30. Scott JAG, Hall AJ, Muyodi C, Lowe B, Ross M, et al. (2000) Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. The Lancet 355: 1225-1230.
31. Murphy SC, Breman JG (2001) Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 64: 57-67.
32. Snow RRW, Craig MM, Deichmann UU, Marsh KK (1999) Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bulletin of the World Health Organization 77: 624-640.
33. PrayGod G, de Frey A, Eisenhut M (2008) Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review. Malaria Journal 7: 210.
34. U.S. Department Of Labor (2009) Consumer Price Index. Available: ftp://ftp. bls.gov/pub/special.requests/cpi/cpiai.txt. Accessed 07/01/2009.
35. World Health Organisation (2004) Sources and Prices of Selected Products for the Prevention, Diagnosis and Treatment of Malaria.
36. Kenya Medical Supplies Agency (2008) Tender prices. Available: http://www.kemsa.co.ke/index.php?option=com_content&view=article&id=34&Itemid=3. Accessed 07/05/09.
37. Hazir T, Fox LM, Nisar YB, Fox MP, Ashraf YP, et al. (2008) Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. The Lancet 371: 49-56.
38. World Health Organisation (2009) WHO CHOICE. Available: http://www.who.int/choice/en/. Accessed 27/01/ 09.
39. Brewster DR, Kwiatkowski D, White NJ (1990) Neurological sequelae of cerebral malaria in children. The Lancet 336: 1039-1043.
40. Manzi F, Hutton G, Schellenberg J, Tanner M, Alonso P, et al. (2008) From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control. BMC Health Services Research 8: 165.
41. Mulligan JA, Mandike R, Palmer N, Williams H, Abdulla S, et al. (2006) The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania. Trop Med Int Health 11: 452-461.
42. Njau J, Goodman C, Kachur SP, Mulligan J, Munkondya J, et al. (2008) The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania. Malaria Journal 7: 4.
43. Murray C, Lopez A (1996) Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. World Health Organisation.
44. World Health Organisation (2008) WHO Statistical Information System (WHOSIS). Available: Accessed 28/11/2008.
45. World Health Organisation (2004) Global burden of disease 2004 update: Disability weights for diseases and conditions.
46. Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, et al. (2008) Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malaria Journal 7: 148.
47. Beyrer C, Suwanvanichkij V, Mullany LC, Richards AK, Franck N, et al. (2006) Responding to AIDS, Tuberculosis, Malaria, and Emerging Infectious Diseases in Burma: Dilemmas of Policy and Practice. PLoS Med 3: e393. doi:310.1371/ journal.pmed.0030393.
48. Dash A, Valecha N, Anvikar A, Kumar A (2008) Malaria in India: Challenges and opportunities. Journal of Biosciences 33: 583-592.
49. Neeraj D, Prabhat J, Vinod PS, Alan AC, Raju MJ, et al. (2010) Adult and child malaria mortality in India: a nationally representative mortality survey. The Lancet.
50. World Bank (1993) World Development Report.
51. World Health Organisation (1996) Investing in health research and development: Report of the Ad Hoc committee on health research relating to future intervention options.
52. International Monetary Fund (2009) World Economic Outlook: a survey by the staff of the International Monetary Fund.
53. Shillcutt S, Walker D, Goodman C, Mills A (2009) Cost-effectiveness in low-and middle-income countries: A review of the debates surrounding decision rules. Pharmacoeconomics 27: 903-917.
54. Morel CM, Lauer JA, Evans DB (2005) Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ 331: 1299-.
55. Tediosi F, Hutton GUY, Maire N, Smith TA, Ross A, et al. (2006) Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania. Am J Trop Med Hyg 75: 131-143.
56. Sinha A, Levine O, Knoll MD, Muhib F, Lieu TA. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. The Lancet 369: 389-396.
57. Jeena P, Thea D, MacLeod W, Chisaka N, Fox M, et al. (2006) Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia. Bull World Health Organ 84: 269-275.
58. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat World Population Prospects: The 2008 Revision. Available: http://esa.un.org/unpp. Accessed 02/11/10.